Evidence map›Paper›PMID 31290019›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020

Changes in body composition during and after adjuvant or neo-adjuvant chemotherapy in women with breast cancer stage I-IIIB compared with changes over a similar timeframe in women without cancer.

M M G A van den Berg, D E Kok, M Visser, J H M de Vries, J Th C M de Kruif, Y de Vries, L Posthuma, D W Sommeijer, A Timmer-Bonte, M Los and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Multilevel Factors for Adiposity Change in a Population-Based Prospective Study of Black Breast Cancer Survivors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Association of bowel radiation dose-volume with skeletal muscle loss during pelvic intensity-modulated radiotherapy in cervical cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  13. Exploring changes in dietary intake, physical activity and body weight during chemotherapy in women with breast cancer: A Mixed-Methods Study.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

M M G A van den BergDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands.
D E KokDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands.
M VisserDepartment of Health Sciences, Faculty of Science, the Amsterdam Public Health Institute, Vrije Universiteit, Amsterdam, the Netherlands.
J H M de VriesDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands.
J Th C M de KruifDepartment of Health Sciences, Faculty of Science, the Amsterdam Public Health Institute, Vrije Universiteit, Amsterdam, the Netherlands.
Y de VriesDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands.
L PosthumaDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands.
D W SommeijerFlevoziekenhuis, Almere, the Netherlands.
A Timmer-BonteAlexander Monro Ziekenhuis, Bilthoven, the Netherlands.
M LosSt Antonius Ziekenhuis, Nieuwegein, the Netherlands.
H W M van LaarhovenAcademisch Medisch Centrum, Amsterdam, the Netherlands.
E KampmanDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands.
Renate M WinkelsDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands. rwinkels@phs.psu.edu.ORCID http://orcid.org/0000-0002-0376-8811
Wageningen University & Research · NLAmsterdam UMC Location University of Amsterdam · NLVrije Universiteit Amsterdam · NLAlexander Monro Ziekenhuis · NLPennsylvania State University · USSt. Antonius Ziekenhuis · NL

Funding

KWF Kankerbestrijding UW2011-4987KWF Kankerbestrijding UW2011-5268
6 · The paper itself

Abstract

purposeBody weight and body composition may change during and after adjuvant or neo-adjuvant chemotherapy for breast cancer. However, most studies did not include a comparison group of women without cancer, thus could not assess whether observed changes differed from age-related fluctuations in body weight and body composition over time. We assessed changes in body composition during and after chemotherapy in breast cancer patients compared with age-matched women not diagnosed with cancer.

methodsWe recruited 181 patients with stage I-IIIb breast cancer and 180 women without cancer. In patients, we assessed body composition using a dual-energy X-ray scan before start of chemotherapy (T1), shortly after chemotherapy (T2), and 6 months after chemotherapy (T3); for the comparison group, the corresponding time points were recruitment (T1) and 6 (T2) and 12 (T3) months.

resultsFifteen percent of patients and 8% of the comparison group gained at least 5% in body weight between T1 and T3. Among the comparison group, no statistically significant changes in body weight, or body composition were observed over time. Body weight of patients significantly increased from baseline (72.1 kg ± 0.4 kg) to T2 (73.3 kg ± 0.4 kg), but decreased to 73.0 kg ± 0.4 kg after chemotherapy (T3). Lean mass of patients significantly increased from 43.1 kg ± 0.5 kg at baseline to 44.0 kg ± 0.5 kg at T2, but returned to 43.1 kg ± 0.5 kg at T3. There were no differential changes in fat mass over time between patients and the comparison group.

conclusionsChanges in body weight and body composition during and after chemotherapy for early stage breast cancer were modest, and did not differ substantially from changes in body weight and body composition among women without cancer.

Indexed as

Absorptiometry, PhotonAdultBody CompositionBody WeightBreast NeoplasmsChemotherapy, AdjuvantFemaleHumansMiddle AgedNeoadjuvant TherapyNeoplasm StagingBody compositionBody weightBreast cancerChemotherapy

Identifiers

PMID31290019
PMCPMC7036066
OpenAlexW2958896884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.